| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8231928 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 8 Pages |
Abstract
The combination of gefitinib and radiation is reasonably well tolerated and has promising activity against nonmetastatic prostate cancer.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Greetta B.M., Timo M.D., Ph.D., Petri M.Sc., B.M., Chandana M.Sc., Jorma M.D., Ph.D., Mirja M.D., Ph.D., Mauri M.D., Ph.D., Patrick A. M.D., Juhani M.D., Sari Ph.D., Akseli M.D., Ph.D.,